Assessment of Lotrafilcon A Contact Lenses
1 other identifier
interventional
118
0 countries
N/A
Brief Summary
The purpose of this 3-month study is to evaluate subjective responses to an upgraded contact lens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2010
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 18, 2010
CompletedFirst Posted
Study publicly available on registry
August 20, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedResults Posted
Study results publicly available
January 24, 2012
CompletedJuly 10, 2012
December 1, 2011
5 months
August 18, 2010
December 20, 2011
June 26, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Overall Comfort
As interpreted by the participant and recorded on a questionnaire as a single, retrospective evaluation of 3 months of wear time. Overall comfort was evaluated binocularly and rated on a 10-point scale, with 1 being poor and 10 being excellent.
3 months of wear, replacing lenses monthly
Secondary Outcomes (1)
Overall Lens Fit
3 months of wear, replacing lenses monthly
Interventions
Silicone hydrogel contact lens approved for daily wear and extended wear up to 30 consecutive nights.
Eligibility Criteria
You may qualify if:
- Have normal ocular findings.
- Be able to wear the study lenses in the available powers.
- Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
- Wear Night \& Day contact lenses.
You may not qualify if:
- Require concurrent ocular medication.
- Eye injury or surgery within twelve weeks prior to enrollment.
- Currently enrolled in an ophthalmic clinical trial.
- Any active corneal infection.
- Corneal refractive surgery.
- Wear AIR OPTIX NIGHT \& DAY AQUA lenses.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CIBA VISIONlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO
- Organization
- Alcon Research, Ltd.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2010
First Posted
August 20, 2010
Study Start
July 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
July 10, 2012
Results First Posted
January 24, 2012
Record last verified: 2011-12